Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study of Belimumab for Children with Systemic Lupus Erythematosus (SLE)
GermanyStudy on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata
BelgiumStudy on the Safety and Effects of IMG-007 for Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy
BelgiumStudy on Oral PHA-022121 for Preventing Angioedema Attacks in Patients with Hereditary Angioedema
AustriaStudy on Upadacitinib for Pain Management in Patients with Psoriatic Arthritis
GermanyStudy on the Effectiveness and Safety of Obinutuzumab for Patients with Systemic Lupus Erythematosus
CzechiaStudy on the Effectiveness and Safety of Cryotherapy and Tirbanibulin for Actinic Keratosis in Organ Transplant Patients
SpainStudy on the Effects of Saccharomyces boulardii CNCM I-745 and Amoxicillin on Gut Health in Patients with Early Lyme Disease Undergoing Antibiotic Treatment
CzechiaStudy on Tofacitinib for Achieving Remission in Early Psoriatic Arthritis Patients Without Prior DMARD Treatment
BelgiumStudy of Ixekizumab Treatment Effects on Joint and Bone Inflammation in Patients with Axial Spondyloarthritis and Psoriatic Arthritis Using Advanced Imaging Methods
DenmarkStudy Comparing Relatlimab and Nivolumab Combination vs. Nivolumab Alone for Patients with Advanced Melanoma
AustriaThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
